Uncategorized
Aldeyra Therapeutics to Participate in Upcoming Conferences
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra or the Company), a biotechnology company developing novel immune-modulating therapies to treat ocular and systemic diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in the following investor conferences: Berenberg US CEO Conference Format: Analyst-Hosted Fireside Chat Date: Wednesday, November 10, 2021 Time: 10:00 a.m. ET Note: A live